Univ. Doz. Dr. Med. Georg S. Kobinia, Stem Cell Therapy - Vienna, Austria

About Univ. Doz. Dr. Med. Georg S. Kobinia

Univ. Doz. Dr. Med. Georg S. Kobinia is a world-renowned, multi-board-certified surgeon and a leading pioneer in Regenerative Medicine and Stem Cell Therapy in Vienna, Austria. With a distinguished medical career spanning over 50 years, Dr. Kobinia has established himself as a prominent figure in the global healthcare landscape, combining decades of high-stakes surgical expertise with cutting-edge advancements in cellular therapies. As the founder of Kobinia Med, he operates at the forefront of medical innovation, transitioning his vast experience in cardiothoracic and vascular surgery into groundbreaking autologous stem cell treatments for neurodegenerative and orthopedic conditions.

Dr. Kobinia’s medical journey is defined by remarkable surgical milestones. He has successfully performed more than 6,000 open-heart operations, 2,000 vascular surgeries, 1,500 thoracic procedures, and over 2,500 regenerative stem cell operations. Throughout his esteemed career, he has continuously pushed the boundaries of modern medicine. He established the Department of Cardiothoracic Surgery in Klagenfurt, Austria, and later founded his specialized stem cell therapy group in Vienna in 2010. His international medical experience is vast, having operated and consulted in countries including Bulgaria, Romania, Iran, Kazakhstan, Serbia, Croatia, England, Egypt, Italy, and the United States.

A prolific researcher and innovator, Dr. Kobinia holds the prestigious postdoctoral lecture qualification from Harvard University’s Massachusetts General Hospital. His dedication to clinical excellence, patient-centric care, and innovative regenerative treatments makes him one of the most sought-after specialists for patients seeking advanced stem cell therapy and comprehensive surgical consultations in Europe.

Medical Expertise & Specializations

Univ. Doz. Dr. Med. Georg S. Kobinia possesses a uniquely diverse medical background that bridges traditional, highly complex operative surgery with advanced regenerative cellular treatments. His medical career began at the Hospital of Lainz (Klinik Hietzing) in Austria, before moving to Linz where he concentrated on thoracic and vascular surgery. During this early period, he achieved significant recognition by describing the subcutaneous implant of the crural bypass and the pioneering implantation of endothelium cells to synthetic prostheses using fibrin glue—a revolutionary method subsequently adopted by numerous international hospitals.

His exceptional talent earned him the prestigious Evarts A. Graham Fellowship from the "American Association for Thoracic Surgery," an honor granted to only one surgeon worldwide annually. Completing this fellowship at the Massachusetts General Hospital at Harvard University in Boston, USA, he authored his professorial dissertation on the prostaglandin metabolism of the heart during cardioplegic arrest. Returning to Austria in 1986, he was appointed head of the new department of cardio-thoracic surgery at Klinikum Klagenfurt, where he secured board certifications in both cardiac and thoracic surgery.

Dr. Kobinia is widely recognized for his clinical inventions and innovations. Collaborating with Warren Hancock, the inventor of biological heart valves, Dr. Kobinia developed a stentless aortic heart valve. He simplified its usage with a novel three-suture method on the commissures, which paved the way for modern percutaneous insertions of aortic heart valves. He also developed the "Kobinia Aortic Root" and the "Kobinia Mammaria Spreader" in 1997. Furthermore, he led initiatives in the resuscitation of frozen and drowned patients using heart-lung machines, successfully resuscitating a drowned child whose heart had stopped for over 30 minutes—a milestone publication ranked among the top 10 globally that year.

In 2010, leveraging his deep understanding of human cellular biology, tissue repair, and complex vascular systems, Dr. Kobinia transitioned into Regenerative Medicine. Founding the stem cell therapy group in Vienna, he has spent over a decade perfecting point-of-care stem cell therapies. Utilizing autologous bone marrow-derived mononuclear cells (BM-MNCs) and CD34+ cells, his clinic provides breakthrough treatments for patients suffering from non-malignant diseases, neurodegenerative disorders like Amyotrophic Lateral Sclerosis (ALS), Spinal Cord Injuries, and Autism Spectrum Disorders.

Conditions Treated

• Neurodegenerative Diseases: Amyotrophic Lateral Sclerosis (ALS) and associated neurological decline.
• Neurodevelopmental Conditions: Autism Spectrum Disorder (ASD) utilizing intrathecal stem cell transplant protocols.
• Orthopedic & Neurological Injuries: Spinal Cord Injuries (SCI) and severe motor function impairments.
• Cerebral Conditions: Cerebral Palsy, focusing on gross motor functioning improvements post-stem cell transplantation.
• Cardiovascular Diseases: Sinus valsalva aneurysm, congenital heart defects, and left ventricular aneurysms.
• Thoracic & Pulmonary Conditions: Pneumothorax, impaired lung tissue, and complicated lung pathologies requiring resection.
• Vascular Conditions: Carotid artery disease, crural graft requirements, and arterial occlusive diseases.

Procedures Performed

• Regenerative Stem Cell Therapy: Over 2,500 operations, including bone marrow aspiration, autologous bone marrow-derived mononuclear cell processing, and intrathecal stem cell transplantation.
• Advanced Open Heart Surgery: Over 6,000 procedures including off-pump bypass surgeries, MIDCAB procedures, and complex congenital heart surgeries.
• Valve Replacements & Reconstructions: Aortic valve procedures (stentless valves, Ross procedure, homografts), mitral valve reconstructions, and pulmonic/tricuspid ring valvuloplasties.
• Vascular Surgery: Over 2,000 operations with a specialized focus on crural bypass grafts and carotid artery surgeries.
• Thoracic & Lung Surgery: Over 1,500 thoracic procedures, VAT-assisted thoracic surgeries, and more than 500 complex lung resections.
• Extracorporeal Circulation Applications: ECMO for rewarming after near-drowning, avalanche suffocation, and complicated lung surgeries.

Education and Training

Univ. Doz. Dr. Med. Georg S. Kobinia’s academic and professional training represents the highest echelons of global medical education, characterized by rigorous fellowships and comprehensive multi-disciplinary board certifications.

• Medical Degree: Medical University of Vienna (Austria).
• Postdoctoral Lecture Qualification (1983): Harvard University, Massachusetts General Hospital, Boston, USA.
• Prestigious Fellowship (1983 – 1984): Evarts A. Graham Fellow of the "American Association for Thoracic Surgery" at Massachusetts General Hospital, Harvard University, Boston, USA.
• Board Certification: General Surgery.
• Board Certification: Cardiac Surgery.
• Board Certification: Thoracic Surgery.
• Board Certification: Vascular Surgery.
• Academic Consultancies: Ekaterina University Hospital, Sofia (Prof. Tschirkov) 2002-2003, and Tissuemed consultancy 1997.

Frequently Asked Questions (FAQ)